Cleared Traditional

K231608 - Teleport XT Microcatheter

K231608 is an FDA 510(k) clearance for Teleport XT Microcatheter, manufactured by OrbusNeich Medical (Shenzhen) Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 219-day FDA review.

K231608 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2024
Decision
219d
Days
Class 2
Risk

K231608 is an FDA 510(k) clearance for the Teleport XT Microcatheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by OrbusNeich Medical (Shenzhen) Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on January 7, 2024 after a review of 219 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all OrbusNeich Medical (Shenzhen) Co., Ltd. devices

FDA 510(k) Submission Details - K231608

510(k) Number K231608 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2023
Decision Date January 07, 2024
Days to Decision 219 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 125d · This submission: 219d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 619
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K231608.
SENDERO Microcatheter
K240384 · Okami Medical, Inc. · Mar 2024
SINC Support Catheter
K233350 · Reflow Medical, Inc. · Feb 2024
WATCHMAN TruSteer Access System (M635TU90050)
K240018 · Boston Scientific Corporation · Feb 2024
TriSalus TriGuideTM Guiding Catheter
K233858 · Trisalus Life Sciences · Dec 2023
SENDERO Microcatheter
K231600 · Okami Medical, Inc. · Nov 2023
091 Balloon Guide Catheter
K231629 · Eosolutions, Corp. · Oct 2023